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BMPR2 variants and COPD in a southern Chinese population (Wang
et al., 2016). They investigated two polymorphisms in the 3′ untranslat-
ed region of the BMPR2 gene. The 3′ untranslated region of an mRNA
molecule is the sequence following the termination codon and plays
an important role in the regulation of gene expression. Wang et al.
found that the less frequent allele of both variants was associated withChronic obstructive pulmonary disease (COPD) is deﬁned as irre- explore themechanistic basis of the ﬁnding (Wang et al., 2016). The ge-versible airﬂow obstruction and is a major cause of morbidity and mor-
tality worldwide. Exposure to cigarette smoke is the major
environmental determinant of COPD but the pathophysiological re-
sponse to smoke is highly variable demonstrating that other factors
are involved. Epidemiological studies have clearly demonstrated that
there is a genetic component to COPD. Targeted analysis of speciﬁc
genes has identiﬁed several common sequence variants (polymor-
phisms) associated with COPD (Bossé, 2012). In addition, genome-
wide analyses have identiﬁed polymorphisms that are implicated in
the pathogenesis of COPD (Pillai et al., 2009) or associated with level
of lung function in the general population (Artigas et al., 2015).
In this issue of EBioMedicine, Wang et al. investigated the bonemor-
phogenetic protein receptor type 2 gene (BMPR2) as a potential genetic
factor involved in the development of COPD (Wang et al., 2016). The au-
thors selected BMPR2 for study due to the anti-inﬂammatory role of this
receptor in endothelial cells (Kim et al., 2013) and evidence that the ex-
pression of this gene is decreasedby exposure to cigarette smoke (Llinas
et al., 2011). BMPR2 encodes a subunit of the receptor for several bone
morphogenetic proteins (BMPs).
As their name suggests, BMPs are a family of growth factors that in-
duce bone formation. However, BMPs have numerous other functions
during development including roles in the generation of the neural
crest, kidney, eye, ear and heart (Wu and Hill, 2009). BMPs also have
functions unrelated to development such as iron metabolism (Parrow
and Fleming, 2014) and glucose homeostasis (Qian et al., 2013). BMPs
signal through a hetero-tetrameric receptor consisting of two type I re-
ceptors that enable signal transduction and two type II receptors that
bind to the ligand. The BMPR2 gene codes for a type II receptor for
BMPs andmutations in this gene have been established as themain ge-
netic cause of pulmonary arterial hypertension (Machado et al., 2015).m.2016.02.004.
. This is an open access article underCOPD and this association was particularly evident in non-smokers.
After demonstrating this novel association, the authors went on to
nomic region containing the BMPR2 variants was cloned into a vector
molecule downstream of a reporter gene (a gene whose expression
can be easily assayed in human cells). The clones were transfected
into a cell line and the results showed that only one of the polymor-
phisms (rs6435156) altered the level of gene expression, suggesting
that it was the causal variant for the associationwith COPD. Speciﬁcally,
the T allele of rs6435156 (that was associated with COPD) resulted in
lower gene expression, which is consistent with an anti-inﬂammatory
role of BMPR2 signaling.
The in vitro effect of rs6435156 on reporter gene function was sup-
ported by quantitative PCR and western blotting data in peripheral
blood mononuclear cells from COPD patients. Wang et al. showed that
there was a dose-dependent decrease in BMPR2mRNA and protein ex-
pression associated with the number of copies of the T allele (Wang
et al., 2016). Furthermore, the effect of genotype on gene expression
was stronger in the presence of cigarette smoke both in vitro and in vivo.
The rs6435156 polymorphismmay affect gene expression levels via
binding with a microRNA (miRNA). miRNA binding to mRNA results in
transcript degradation or the inhibition of translation initiation. Wang
et al. found that rs6435156 is located in a region that is predicted to
bind a miRNA known as hsa-miR-20a. If the T allele of rs6435156 en-
hanced the binding of hsa-miR-20a it would be expected to result in de-
creased BMPR2 expression levels. The authors showed that mimics of
hsa-miR-20a did indeed result in decreased gene expression and this ef-
fect was only signiﬁcant for the T allele of the variant (Wang et al.,
2016).
This is an interesting study that includes a novel genetic epidemio-
logical observation and convincing mechanistic data (Wang et al.,
2016). The paper is a welcome addition to the literature as the genetic
aspects of COPD have been underexplored in the Chinese population.
However, a number of issues remain to be addressed. First, the associa-
tion of these polymorphisms with COPD needs to be replicated in addi-
tional Chinese populations and examined in other racial groups. Giventhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
19A.J. Sandford / EBioMedicine 5 (2016) 18–19the likely importance of exposure to cigarette smoke it would be impor-
tant to determine the genetic effect size in cases and controls with an
equal smoking history. Second, there is an apparent contradiction be-
tween the epidemiological data showing the strongest association in
non-smoking patients and the gene/protein expression data that dem-
onstrate a larger genotype effect in the presence of cigarette smoke.
Nevertheless, if these issues can be resolved the BMPs and their recep-
tors may represent novel targets for therapeutic interventions in COPD
patients.
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